Page 12 - Micro Biosystems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its competitors? We will compare Rapid Micro Biosystems to related companies based on the strength of its dividends, analyst recommendations, earnings, risk, profitability, institutional ownership and valuation. Analyst Recommendations This is […]

Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) posted its earnings results on Tuesday. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($0.02), MarketWatch Earnings reports. Rapid Micro Biosystems had a negative net margin of 316.48% and a negative return on equity of 177.70%. Shares of RPID […]

Pharmaceutical Sterility Testing Market Trends and Insights by Product Type (Kits & Reagents, Instruments, and Services), By Sample (Medical Devices,...

Codex DNA (NASDAQ:DNAY – Get Rating) and Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Profitability This table compares Codex DNA and Rapid […]

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Sterility Testing Global Market Report 2022: By Sample, By Product, By Type, By Test, By End- User" report has been added to ResearchAndMarkets.com's offering.The global pharmaceutical sterility testing market is expected to grow from $1.09 billion in 2021 to $1.19 billio...